UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Tag: CRISPR

Plant biotech in Europe: Present and future

Marcel Kuntz is a panellist for the panel discussion on the regulatory landscape for plant biotechnology at the 8th Plant Genomics & Gene Editing Congress: Europe. Here he provides us with some background for the discussion.

Read More

Wild wheat, plant genomics, and food security

Wheat is the most widely grown crop in the world, providing 20% of the calories and proteins consumed by humankind. More than one fifth of the projected yield is lost every year to disease. Dr Brande Wulff, Group Leader at the John Innes Centre, and speaker at the 8th Plant Genomics and Gene Editing Congress, Europe, is leading research aiming to reduce the proportion of wheat lost to pathogens and increase global food security…

Read More

The future of GMOs, gene editing and plant biotechnology in post-Brexit UK

Growing and selling genetically modified organisms (GMOs) is permitted in the UK but GMO products are subject to a lengthy and stringent EU authorization process. There are currently no GM crops grown commercially in the UK, but they are imported. So, what is the UK’s relationship with GM products, and where do we stand on gene editing? We spoke with Nigel Halford, Principal Research Scientist at Rothamsted Research, UK.

Read More

Acrylamide, Plant Genomics and the Food Industry

Ahead of the 8th Plant Genomics and Gene Editing Congress, we asked keynote speaker Nigel Halford, Principal Research Scientist at Rothamsted Research, UK, to share with us the background to his research…

Read More

Presentation Slides from the 7th Plant Genomics & Gene Editing Congress: USA

The recent 7th Plant Genomics Congress: USA provided a fantastic opportunity to discover how novel gene-editing technologies, CRISPR and other ‘omics’ technologies are being applied to research and product development. We have made the following slides from Jerry Feitelson, Lynne Reuber, Greg Bryan and Chloe Pavely available to view.

Read More

How CRISPR will guide the way to better cancer therapies

This article was originally published on Open Targets and is republished with kind permission.

For many cancers we don’t have an effective treatment option, and worse still, a lot of the therapies that we use are just not good enough. We need better cancer therapies, and we need them now.

The reason we need new therapies is actually the reason why I got into cancer research. It goes back to when I was only 17 when my Mam was diagnosed with acute myeloid leukemia (AML). She went through her treatment, chemotherapy, with another 12 patients, and unfortunately she was the only one who survived.

Read More

The Top 5 Plant Genomics Articles of 2018

It has been an eventful year for plant genomics: we’ve seen advancements in plant disease research, the sequencing of the wheat genome, which was finally achieved through a worldwide collaboration of researchers spanning 13 years, and the ruling on the legal status of gene-edited crops. 

As 2018 draws to a close, we thought it was a good time to reflect. Here, we’ve collated our top articles of the year.

Read More

Microbiome within Plants, the Rhizophagy cycle and metagenomic discovery strategies

As a result of revolutionary breakthroughs in recent years, plant research has evolved dramatically. At the 6th Plant Genomics & Gene Editing Congress: USA, the latest NGS, “omic” and gene editing technologies being used for progressing plant based research were examined. If you weren’t able to be there in person, these slides are now available from Sharon Doty, James White & Axel Visel.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive